Allopurinol

Producers shown on SFDA

(Record date:05/09/2021）

Producers shown on EP

(Quoted from EP website；record date:05/09/2021）

Producer:Wuxi Taxus Pharmaceutical Co., Ltd. (formerly Jiangsu Yew Pharmaceutical Co., Ltd.) was established in 2004. It is a pharmaceutical enterprise subordinate to Hongdou Group in the field of big health industry,.

The API factory has built a standard workshop of 28800 square meters according to GMP standards, has advanced automatic production lines at home and abroad, and is equipped with a full set of raw material processing equipment, advanced testing instruments and supporting sewage treatment system. A complete set of processing technology from paclitaxel crude products to high-quality products has been formed, and more than 300 kg of paclitaxel finished products can be extracted every year. The preparation factory adopts advanced and standardized GMP design concept, selects international production equipment and testing instruments, and can produce various specifications of anti-tumor drug injection and freeze-dried powder injection, with an annual production of 6 million anti-tumor drug injections.

Registered capital:RMB 80 million

Producer:Chongqing Southwest Synthetic Pharmaceutical Co., Ltd., founded in 1965 (formerly known as Southwest Synthetic Pharmaceutical Factory), is now controlled by Peking University Founder group. The company has a complete product structure, mainly including more than 10 categories, including sulfonamides, antipyretics and analgesics, total anti and semi synthetic anti, vitamins, quinolones, anti ulcer drugs, anti anxiety drugs, antihypertensive drugs, anti allergic drugs, antiemetic drugs, anticancer drugs, cardiovascular drugs and more than 100 varieties of APIs and preparations. All products of Southwest synthesis have passed GMP certification, of which 7 products have passed FDA certification and 5 products have obtained European cos certificate.

Staff size:/

Registered capital:RMB 250 million

Producer:Heilongjiang Maizhilun Pharmaceutical Co., Ltd. was established in 2009. Its main industry is manufacturing. The company's business scope includes: manufacturing of API (soybean phospholipid powder, sodium azulene sulfonate, allopurinol), etc
Staff size:About 50 persons

Registered capital:RMB 5 million